cattle health 
resolution and position statement

 

Use of Bovine Blood

BACKGROUND: Bovine spongiform encephalopathy (BSE) is a chronic, degenerative disorder affecting the nervous system of cattle.  It is associated with consumption of animal proteins contaminated with specific risk materials containing the infective agent.

 

Fifteen years of scientific research has demonstrated no detectable BSE agent in Bovine blood and no transmission of BSE from cow to cow through blood.  Bovine blood is not classified as an SRM by the OIE.

 

Plasma, serum and fractions thereof contain biologically important components, including immunoglobulins, which may be used in colostrum supplements, colostrum replacers and feed supplements to reduce risk of transmission of Johne’s disease, brucellosis and other economically important diseases transmitted via colostrum.

 

RESOLUTION: The National Institute for Animal Agriculture (NIAA), based on current science, encourages FDA to retain the current bovine blood and blood products exemption to the ruminant feed ban, including plasma, serum and fractions thereof for diets used in ruminants and non-ruminants. 

 

Approved: 2004   |   Amended: 2005
 

The Cattle Health committee objectives are to facilitate the development and implementation of programs to control and eradicate beef and dairy cattle diseases and programs to assure the wholesomeness of food products derived from milk and beef.  

Reprinting of this resolution is encouraged.

 

National Institute for Animal Agriculture | 1910 Lyda Avenue | Bowling Green, KY 42104-5809
Phone (270) 782-9798 | Fax (270) 782-0188 | NIAA@animalagriculture.org | www.animalagriculture.org